How State Scrutiny Is Impacting Healthcare Private Equity Ownership

How State Scrutiny Is Impacting Healthcare Private Equity Ownership

Created by Grace Totman, Co-Head of Capstone’s Healthcare Practice

Regulatory scrutiny around healthcare consolidation – specifically private equity investments – has increased over the past couple of years. Although federal investigations often receive the most headline attention, Capstone believes that state-level scrutiny will be more impactful in the long term and should be top of mind for investors. This scrutiny often manifests in “notice” or disclosure requirements, which we estimate exist in at least ten states. These laws require disclosure of transactions (at certain thresholds) involving a healthcare entity. Notice laws also typically target acquisitions of or investments in provider groups, reflecting a focus on Physician Practice Management (PPM) rollups.  

In this tracker, Capstone provides analysis of the existing state-level regulation/legislation in this space, including applicability, materiality thresholds, and particular reporting requirements.

Have a question?

We want to hear from you. Let us know your question and a research analyst will get back to you promptly. We love to discuss our research.

Connect

Our Latest Insights

Google Search Remedy: Data-Sharing Creates Opportunities for Rivals

Google Search Remedy: Data-Sharing Creates Opportunities for Rivals

September 16, 2025 By Ian Tang and Kate Lardner, TMT Analysts Capstone believes a federal court’s decision requiring  Alphabet Inc.’s Google to share the index that powers its search engine with search engine rivals and generative artificial intelligence (GenAI)...